Virtu Financial’s Propanc Biopharma PPCB Stock Holding History

Virtu Financial’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,630	Closed	-$4K	–	2445
2026 Q1	$4K	Buy	+1,630	New	+$9.67K	﹤0.01%	1524
2025 Q4	–	Sell	-1,667	Closed	-$71K	–	2453
2025 Q3	$71K	Buy	+1,667	New	+$108K	﹤0.01%	1088

Other funds holding PPCB

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Virtu Financial's PPCB Position: Q2 2026 in Review

Virtu Financial sold out of Propanc Biopharma (PPCB) in Q2 2026, closing a stake of 1,630 shares — an estimated $4K sold.

Virtu Financial first reported a position in PPCB in Q3 2025 and held it in 2 quarters. The position peaked at $71K in Q3 2025. 4 funds tracked by Wall St. Rank hold PPCB as of Q2 2026.

Virtu Financial reported no remaining Propanc Biopharma position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 1,630 Propanc Biopharma shares in Q2 2026, an estimated $4K.
Virtu Financial first reported a position in Propanc Biopharma in Q3 2025 and held it in 2 quarters.
Virtu Financial's Propanc Biopharma position peaked at $71K in Q3 2025.
4 funds tracked by Wall St. Rank held Propanc Biopharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.